Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04767347 · ClinicalTrials.gov registry record · NA

Renal Considerations in the Heat Stress Recommendations

A NA study, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT04767347: Completed NA study, sponsored by Indiana University.

NCT04767347 is a NA study that has completed, run by Indiana University. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04767347, a NA study, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

An epidemic of chronic kidney disease is occurring in laborers who undertake physical work outdoors in hot conditions. The reason for this is unknown, but may be related to kidney dysfunction caused by increases in body temperature and dehydration. The current heat stress recommendations for workers were not developed with regards for kidney health. The purpose of this study is to determine if the current recommendations protect against kidney dysfunction.

Primary Outcome

Kidney injury marker

Interventions

  • OTHER 23.0°C WBGT - Fixed Work Rate
  • OTHER 25.5°C WBGT - Fixed Work Rate
  • OTHER 27.5°C WBGT - Fixed Work Rate
  • OTHER 28.5°C WBGT - Fixed Work Rate
  • OTHER 35.5°C WBGT - Fixed Work Rate

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2021-03-01
Est. Completion 2023-05-04
Phase NA
Indiana University

890 total trials

What the finished NCT04767347 record still lists

NCT04767347 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 5 interventions - of which 23.0°C WBGT - Fixed Work Rate is the first listed.

NCT04767347 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04767347 about?

NCT04767347 is a clinical study titled "Renal Considerations in the Heat Stress Recommendations". An epidemic of chronic kidney disease is occurring in laborers who undertake physical work outdoors in hot conditions. The reason for this is unknown, but may be related to kidney dysfunction caused by increases in body temperature and dehydration. The current heat stress recommendations for workers...

What is the current status of trial NCT04767347?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2021-03-01. Estimated completion is 2023-05-04.

What interventions are being tested in trial NCT04767347?

The interventions under investigation include: 23.0°C WBGT - Fixed Work Rate (OTHER), 25.5°C WBGT - Fixed Work Rate (OTHER), 27.5°C WBGT - Fixed Work Rate (OTHER), 28.5°C WBGT - Fixed Work Rate (OTHER), 35.5°C WBGT - Fixed Work Rate (OTHER).

Who is sponsoring clinical trial NCT04767347?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04767347's enrollment target sits among peer trials

38 1538th of 2000 higher than 461 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01684904 · 38 participants · NA

    Proton Therapy for Esophageal Cancer

  • NCT03310879 · 38 participants · Phase 2

    Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

  • NCT03896269 · 38 participants · Phase 1

    CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

  • NCT04085315 · 38 participants · Phase 1

    Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04767347, the US trial registry maintained by the National Library of Medicine. NCT04767347 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.